Literature DB >> 11439001

Pseudoxanthoma elasticum: Point mutations in the ABCC6 gene and a large deletion including also ABCC1 and MYH11.

I Meloni1, P Rubegni, G De Aloe, M Bruttini, E Pianigiani, R Cusano, M Seri, S Mondillo, A Federico, A M Bardelli, L Andreassi, M Fimiani, A Renieri.   

Abstract

Pseudoxanthoma elasticum (PXE) is a mendelian disorder characterized by calcification of elastic fibers in skin, arteries, and retina. It results in dermal lesions, arterial insufficiency and retinal hemorrhages, leading to macular degeneration. PXE is transmitted either as an autosomal dominant or recessive trait and several sporadic cases have been observed. Mutations in the ABCC6 gene have been identified very recently in patients. Here, we report on a large Italian family affected by pseudoxanthoma elasticum for which linkage analysis had pointed to a region encompassing markers D16S3069-D16S405-D16S3103; hemizygosity of marker D16S405 allowed us to detect a submicroscopic deletion of at least 900 kb involving ABCC6, ABCC1, and MYH11. Mutation analysis on the other allele of the family, as well as on two additional sporadic cases, revealed nonsense (Y227X, R518X, R1164X) and frame-shift (c.960delC) mutations in ABCC6 (MRP6) further confirming the role of this multi-drug resistance gene in the etiology of pseudoxanthoma elasticum. Furthermore, clinical re-examination of members of the family harboring the deletion led to the detection of additional features, potentially caused by the deletion of the MYH11 gene. In the course of the analysis five nonpathogenic variants were found in ABCC6: 1233T>C, 1245G>A, 1838 T>G (V614A), 1890C>G, and 3506+83C>A. Hum Mutat 18:85, 2001. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11439001     DOI: 10.1002/humu.1157

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

Review 1.  [Pseudoxanthoma elasticum].

Authors:  M S Ladewig; C Götting; C Szliska; P C Issa; H-M Helb; I Bedenicki; H P N Scholl; F G Holz
Journal:  Ophthalmologe       Date:  2006-06       Impact factor: 1.059

2.  Development of a rapid, reliable genetic test for pseudoxanthoma elasticum.

Authors:  Yanggu Shi; Sharon F Terry; Patrick F Terry; Lionel G Bercovitch; Gary F Gerard
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

3.  New ABCC6 gene mutations in German pseudoxanthoma elasticum patients.

Authors:  Doris Hendig; Veronika Schulz; Jutta Eichgrün; Christiane Szliska; Christian Götting; Knut Kleesiek
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

4.  Analysis of ABCC6 (MRP6) in normal human tissues.

Authors:  Konstanze Beck; Kimiko Hayashi; Ka'ohimanu Dang; Masando Hayashi; Charles D Boyd
Journal:  Histochem Cell Biol       Date:  2005-05-12       Impact factor: 4.304

Review 5.  Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations.

Authors:  N Chassaing; L Martin; P Calvas; M Le Bert; A Hovnanian
Journal:  J Med Genet       Date:  2005-05-13       Impact factor: 6.318

6.  Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by pseudoxanthoma elasticum.

Authors:  Ellen G Pfendner; Olivier M Vanakker; Sharon F Terry; Sophia Vourthis; Patricia E McAndrew; Monica R McClain; Sarah Fratta; Anna-Susan Marais; Susan Hariri; Paul J Coucke; Michele Ramsay; Denis Viljoen; Patrick F Terry; Anne De Paepe; Jouni Uitto; Lionel G Bercovitch
Journal:  J Med Genet       Date:  2007-07-06       Impact factor: 6.318

Review 7.  Multidrug resistance associated proteins in multidrug resistance.

Authors:  Kamlesh Sodani; Atish Patel; Rishil J Kathawala; Zhe-Sheng Chen
Journal:  Chin J Cancer       Date:  2011-11-18

8.  The ABCC6 transporter: what lessons can be learnt from other ATP-binding cassette transporters?

Authors:  Olivier M Vanakker; Mohammad J Hosen; Anne De Paepe
Journal:  Front Genet       Date:  2013-10-16       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.